Annual EPS
-$6.00
+$3.90+39.39%
December 31, 2023
Summary
- As of February 8, 2025, BCLI annual earnings per share is -$6.00, with the most recent change of +$3.90 (+39.39%) on December 31, 2023.
- During the last 3 years, BCLI annual EPS has risen by +$10.05 (+62.62%).
- BCLI annual EPS is now -188.89% below its all-time high of $6.75, reached on December 31, 2009.
Performance
BCLI EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.51
+$0.09+15.00%
September 30, 2024
Summary
- As of February 8, 2025, BCLI quarterly earnings per share is -$0.51, with the most recent change of +$0.09 (+15.00%) on September 30, 2024.
- Over the past year, BCLI quarterly EPS has increased by +$0.09 (+15.00%).
- BCLI quarterly EPS is now -102.37% below its all-time high of $21.54, reached on March 31, 2004.
Performance
BCLI Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$3.51
-$0.06-1.74%
September 30, 2024
Summary
- As of February 8, 2025, BCLI TTM earnings per share is -$3.51, with the most recent change of -$0.06 (-1.74%) on September 30, 2024.
- Over the past year, BCLI TTM EPS has dropped by -$0.06 (-1.74%).
- BCLI TTM EPS is now -117.34% below its all-time high of $20.24, reached on March 31, 2004.
Performance
BCLI TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
BCLI EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.4% | +15.0% | -1.7% |
| 3 y3 years | +62.6% | +15.0% | -1.7% |
| 5 y5 years | +42.9% | +15.0% | -1.7% |
BCLI EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.2% | -13.3% | +82.1% | -1.7% | +66.6% |
| 5 y | 5-year | at high | +62.6% | -13.3% | +90.8% | -1.7% | +79.8% |
| alltime | all time | -188.9% | +97.4% | -102.4% | +99.7% | -117.3% | +98.4% |
Brainstorm Cell Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.51(-15.0%) | -$3.51(+1.7%) |
| Jun 2024 | - | -$0.60(-20.0%) | -$3.45(-28.1%) |
| Mar 2024 | - | -$0.75(-54.5%) | -$4.80(-22.0%) |
| Dec 2023 | -$6.00(-39.4%) | -$1.65(+266.7%) | -$6.15(-4.7%) |
| Sep 2023 | - | -$0.45(-76.9%) | -$6.45(-27.1%) |
| Jun 2023 | - | -$1.95(-7.1%) | -$8.85(-9.2%) |
| Mar 2023 | - | -$2.10(+7.7%) | -$9.75(-1.5%) |
| Dec 2022 | -$9.90(-2.9%) | -$1.95(-31.6%) | -$9.90(-5.7%) |
| Sep 2022 | - | -$2.85(0.0%) | -$10.50(+6.1%) |
| Jun 2022 | - | -$2.85(+26.7%) | -$9.90(+3.1%) |
| Mar 2022 | - | -$2.25(-11.8%) | -$9.60(-5.9%) |
| Dec 2021 | -$10.20(-36.4%) | -$2.55(+13.3%) | -$10.20(-22.7%) |
| Sep 2021 | - | -$2.25(-11.8%) | -$13.20(+1.1%) |
| Jun 2021 | - | -$2.55(-10.5%) | -$13.05(-8.4%) |
| Mar 2021 | - | -$2.85(-48.6%) | -$14.25(-12.0%) |
| Dec 2020 | -$16.05(+0.9%) | -$5.55(+164.3%) | -$16.20(+2.9%) |
| Sep 2020 | - | -$2.10(-44.0%) | -$15.75(-9.5%) |
| Jun 2020 | - | -$3.75(-21.9%) | -$17.40(+1.8%) |
| Mar 2020 | - | -$4.80(-5.9%) | -$17.10(+7.5%) |
| Dec 2019 | -$15.90(+51.4%) | -$5.10(+36.0%) | -$15.90(+7.1%) |
| Sep 2019 | - | -$3.75(+8.7%) | -$14.85(+11.2%) |
| Jun 2019 | - | -$3.45(-4.2%) | -$13.35(+8.5%) |
| Mar 2019 | - | -$3.60(-11.1%) | -$12.30(+17.1%) |
| Dec 2018 | -$10.50(+169.2%) | -$4.05(+80.0%) | -$10.50(+70.7%) |
| Sep 2018 | - | -$2.25(-6.3%) | -$6.15(+5.1%) |
| Jun 2018 | - | -$2.40(+33.3%) | -$5.85(+34.5%) |
| Mar 2018 | - | -$1.80(-700.0%) | -$4.35(+7.4%) |
| Dec 2017 | -$3.90(-3.7%) | $0.30(-115.4%) | -$4.05(-18.2%) |
| Sep 2017 | - | -$1.95(+116.7%) | -$4.95(+13.8%) |
| Jun 2017 | - | -$0.90(-40.0%) | -$4.35(+3.6%) |
| Mar 2017 | - | -$1.50(+150.0%) | -$4.20(0.0%) |
| Dec 2016 | -$4.05(-41.3%) | -$0.60(-55.6%) | -$4.20(-9.7%) |
| Sep 2016 | - | -$1.35(+80.0%) | -$4.65(-13.9%) |
| Jun 2016 | - | -$0.75(-50.0%) | -$5.40(-16.3%) |
| Mar 2016 | - | -$1.50(+42.9%) | -$6.45(-4.4%) |
| Dec 2015 | -$6.90(-32.4%) | -$1.05(-50.0%) | -$6.75(-19.6%) |
| Sep 2015 | - | -$2.10(+16.7%) | -$8.40(-3.4%) |
| Jun 2015 | - | -$1.80(0.0%) | -$8.70(-6.5%) |
| Mar 2015 | - | -$1.80(-33.3%) | -$9.30(-8.8%) |
| Dec 2014 | -$10.20(+47.8%) | -$2.70(+12.5%) | -$10.20(+13.3%) |
| Sep 2014 | - | -$2.40(0.0%) | -$9.00(+11.1%) |
| Jun 2014 | - | -$2.40(-11.1%) | -$8.10(+1.9%) |
| Mar 2014 | - | -$2.70(+80.0%) | -$7.95(+6.0%) |
| Dec 2013 | -$6.90 | -$1.50(0.0%) | -$7.50(+25.0%) |
| Sep 2013 | - | -$1.50(-33.3%) | -$6.00(-11.1%) |
| Jun 2013 | - | -$2.25(0.0%) | -$6.75(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | -$2.25(<-9900.0%) | -$6.75(0.0%) |
| Dec 2012 | -$4.50(-33.3%) | $0.00(-100.0%) | -$6.75(-25.0%) |
| Sep 2012 | - | -$2.25(0.0%) | -$9.00(0.0%) |
| Jun 2012 | - | -$2.25(0.0%) | -$9.00(+100.0%) |
| Mar 2012 | - | -$2.25(0.0%) | -$4.50(0.0%) |
| Dec 2011 | -$6.75(0.0%) | -$2.25(0.0%) | -$4.50(0.0%) |
| Sep 2011 | - | -$2.25(-200.0%) | -$4.50(0.0%) |
| Jun 2011 | - | $2.25(-200.0%) | -$4.50(-50.0%) |
| Mar 2011 | - | -$2.25(0.0%) | -$9.00(0.0%) |
| Dec 2010 | -$6.75(-200.0%) | -$2.25(0.0%) | -$9.00(-233.3%) |
| Sep 2010 | - | -$2.25(0.0%) | $6.75(0.0%) |
| Jun 2010 | - | -$2.25(0.0%) | $6.75(0.0%) |
| Mar 2010 | - | -$2.25(-116.7%) | $6.75(0.0%) |
| Dec 2009 | $6.75(-142.9%) | $13.50(-700.0%) | $6.75(-175.0%) |
| Sep 2009 | - | -$2.25(0.0%) | -$9.00(0.0%) |
| Jun 2009 | - | -$2.25(0.0%) | -$9.00(-20.0%) |
| Mar 2009 | - | -$2.25(0.0%) | -$11.25(-28.6%) |
| Dec 2008 | -$15.75(-66.7%) | -$2.25(0.0%) | -$15.75(-36.4%) |
| Sep 2008 | - | -$2.25(-50.0%) | -$24.75(-21.4%) |
| Jun 2008 | - | -$4.50(-33.3%) | -$31.50(-12.5%) |
| Mar 2008 | - | -$6.75(-40.0%) | -$36.00(-20.0%) |
| Dec 2007 | -$47.25(+23.5%) | -$11.25(+25.0%) | -$45.00(+33.3%) |
| Sep 2007 | - | -$9.00(0.0%) | -$33.75(0.0%) |
| Jun 2007 | - | -$9.00(-42.9%) | -$33.75(0.0%) |
| Mar 2007 | - | -$15.75(+75.0%) | -$33.75(+2.7%) |
| Dec 2006 | -$38.25(+13.3%) | - | - |
| Sep 2006 | - | -$9.00(0.0%) | -$32.85(-6.4%) |
| Jun 2006 | - | -$9.00(+53.8%) | -$35.10(0.0%) |
| Mar 2006 | - | -$5.85(-35.0%) | -$35.10(+20.0%) |
| Mar 2006 | -$33.75(-85.1%) | - | - |
| Dec 2005 | - | -$9.00(-20.0%) | -$29.25(-85.7%) |
| Sep 2005 | - | -$11.25(+25.0%) | -$203.85(-5.2%) |
| Jun 2005 | - | -$9.00(-95.1%) | -$215.10(+16.3%) |
| Mar 2005 | -$227.25(>+9900.0%) | - | - |
| Dec 2004 | - | -$183.60(+716.0%) | -$185.02(+7169.6%) |
| Sep 2004 | - | -$22.50(+4837.4%) | -$2.55(-112.8%) |
| Jun 2004 | - | -$0.46(-102.1%) | $19.89(-1.7%) |
| Mar 2004 | -$0.96(-14.3%) | $21.54(-2014.3%) | $20.24(-1555.0%) |
| Dec 2003 | - | -$1.13(+1729.3%) | -$1.39(+307.6%) |
| Sep 2003 | - | -$0.06(-45.3%) | -$0.34(+4.9%) |
| Jun 2003 | - | -$0.11(+22.5%) | -$0.33(+24.7%) |
| Mar 2003 | -$1.13(+690.0%) | -$0.09(+21.8%) | -$0.26(+54.4%) |
| Dec 2002 | - | -$0.08(+65.7%) | -$0.17(+80.6%) |
| Sep 2002 | - | -$0.05(-5.2%) | -$0.09(+94.8%) |
| Jun 2002 | - | -$0.05 | -$0.05 |
| Mar 2002 | -$0.14 | - | - |
FAQ
- What is Brainstorm Cell Therapeutics annual earnings per share?
- What is the all time high annual EPS for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual EPS year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly EPS year-on-year change?
- What is Brainstorm Cell Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics TTM EPS year-on-year change?
What is Brainstorm Cell Therapeutics annual earnings per share?
The current annual EPS of BCLI is -$6.00
What is the all time high annual EPS for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual earnings per share is $6.75
What is Brainstorm Cell Therapeutics annual EPS year-on-year change?
Over the past year, BCLI annual earnings per share has changed by +$3.90 (+39.39%)
What is Brainstorm Cell Therapeutics quarterly earnings per share?
The current quarterly EPS of BCLI is -$0.51
What is the all time high quarterly EPS for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly earnings per share is $21.54
What is Brainstorm Cell Therapeutics quarterly EPS year-on-year change?
Over the past year, BCLI quarterly earnings per share has changed by +$0.09 (+15.00%)
What is Brainstorm Cell Therapeutics TTM earnings per share?
The current TTM EPS of BCLI is -$3.51
What is the all time high TTM EPS for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high TTM earnings per share is $20.24
What is Brainstorm Cell Therapeutics TTM EPS year-on-year change?
Over the past year, BCLI TTM earnings per share has changed by -$0.06 (-1.74%)